Structure of compound 4j

5-HT2 antagonist and 5-HT7 inverse agonist

brain penetrant, oral efficacy in rodent models

backup candidate to JNJ-18038683

Bioorg. Med. Chem. Lett., Nov. 7, 2020

Janssen, San Diego, CA

“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.